Optimizing the Colloid Particle Concentration for Improved Preoperative and Intraoperative Image-guided Detection of Sentinel Nodes in Prostate Cancer

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2010 Mar 23

PMID 20306033

Citations 7

Authors

Lenka Vermeeren

Sara H Muller

Willem Meinhardt

Renato A Valdes Olmos

Affiliations

Soon will be listed here.

Abstract

Purpose: Lymphatic mapping for prostate cancer can be used to determine therapeutic strategies. Sentinel node visualization requires sufficient nodal tracer uptake. We evaluated the effect of an increase in particle concentration on preoperative and intraoperative sentinel node depiction.

Methods: Enrolled in the study were 50 consecutive patients with prostate cancer. The first 25 patients (group A) received nanocolloid with standard labelling (0.4 ml (99m)Tc per 0.1 mg nanocolloid). The last 25 patients (group B) received nanocolloid with a reduced labelling dilution volume (0.4 ml (99m)Tc per 0.2 mg nanocolloid). The aimed injected volume and dosage were the same for both groups (225 MBq in 0.4 ml). Intratumoral tracer injection was followed by planar lymphoscintigraphy (15 min and 2 h), SPECT/CT and laparoscopic sentinel lymphadenectomy. Lymph node visualization was evaluated using a four-point scoring system (0 nonvisualization to 3 intense visualization) and count quantification on the 2-h anterior lymphoscintigram. In addition to the gamma ray detection probe, a portable gamma camera was used for intraoperative sentinel node visualization.

Results: Preoperative visualization in group A was 88% (mean 2.0 sentinel nodes per patient) versus 100% in group B (mean 2.6 sentinel nodes per patient). Visualization scores (p=0.008), total counts (p=0.001) and maximum counts per pixel (p=0.034) in the sentinel nodes were significantly better in group B. This also led to more efficient intraoperative detection of the sentinel nodes with the portable gamma camera (84% in group A versus 100% in group B).

Conclusion: Enhancement of the particle concentration may lead to significant improvement in sentinel node visualization and intraoperative localization in patients with prostate cancer. Further research regarding optimization of radiotracer labelling by changing the particle concentration is warranted.

Citing Articles

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Kuusk T, Donswijk M, Olmos R, De Bruijn R, Brouwer O, Hendricksen K EJNMMI Res. 2018; 8(1):105.

PMID: 30511175 PMC: 6277398. DOI: 10.1186/s13550-018-0460-y.

Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?.

Brouwer O, van der Poel H, Bevers R, van Gennep E, Horenblas S Clin Transl Imaging. 2016; 4(5):395-410.

PMID: 27738628 PMC: 5037151. DOI: 10.1007/s40336-016-0189-4.

Fluorescence guided surgery and tracer-dose, fact or fiction?.

KleinJan G, Bunschoten A, van den Berg N, Olmos R, Klop W, Horenblas S Eur J Nucl Med Mol Imaging. 2016; 43(10):1857-67.

PMID: 27020580 PMC: 4969335. DOI: 10.1007/s00259-016-3372-y.

Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping?.

Vidal-Sicart S, van Leeuwen F, van den Berg N, Olmos R Eur J Nucl Med Mol Imaging. 2015; 42(11):1627-1630.

PMID: 26194719 DOI: 10.1007/s00259-015-3132-4.

Comment on: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

Aprile C, Buroni F, Lodola L, Persico M Eur J Nucl Med Mol Imaging. 2014; 41(6):1257-8.

PMID: 24668275 DOI: 10.1007/s00259-014-2747-1.

References

Jeschke S, Nambirajan T, Leeb K, Ziegerhofer J, Sega W, Janetschek G . Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol. 2005; 173(6):1943-6. DOI: 10.1097/01.ju.0000158159.16314.eb. View

Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K . Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin. Breast Cancer. 2000; 7(1):87-94. DOI: 10.1007/BF02967195. View

Conway W, Faries M, Nicholl M, Terando A, Glass E, Sim M . Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol. 2009; 16(6):1548-52. PMC: 2752947. DOI: 10.1245/s10434-009-0420-x. View

Leidenius M, Leppanen E, Krogerus L, Smitten K . The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer. Nucl Med Commun. 2004; 25(3):233-8. DOI: 10.1097/00006231-200403000-00004. View

Krynyckyi B, Zhang Z, Kim C, Lipszyc H, Mosci K, Machac J . Effect of high specific-activity sulfur colloid preparations on sentinel node count rates. Clin Nucl Med. 2002; 27(2):92-5. DOI: 10.1097/00003072-200202000-00003. View

Valdes Olmos R, Tanis P, Hoefnagel C, Nieweg O, Muller S, Rutgers E . Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun. 2001; 22(5):579-86. DOI: 10.1097/00006231-200105000-00018. View

Vermeeren L, Valdes Olmos R, Meinhardt W, Bex A, van der Poel H, Vogel W . Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol Imaging. 2009; 36(7):1029-36. DOI: 10.1007/s00259-009-1100-6. View

Sato K, Krag D, Tamaki K, Anzai M, Tsuda H, Kosuda S . Optimal particle size of radiocolloid for sentinel node identification in breast cancer-electron microscopic study and clinical comparison. Breast Cancer. 2004; 11(3):256-63. DOI: 10.1007/BF02984546. View

Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C . Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging. 2007; 35(1):32-8. DOI: 10.1007/s00259-007-0516-0. View

10.

Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A . Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med. 2008; 33(4):262-7. DOI: 10.1097/RLU.0b013e3181662fc7. View

11.

Leijte J, van der Ploeg I, Olmos R, Nieweg O, Horenblas S . Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med. 2009; 50(3):364-7. DOI: 10.2967/jnumed.108.059733. View

12.

Silva Jr N, Anselmi C, Anselmi O, Madke R, Hunsche A, Souto J . Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl Med Commun. 2005; 26(12):1081-6. DOI: 10.1097/00006231-200512000-00006. View

13.

Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E . Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007; 48(2):201-6. View

14.

Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J . Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging. 2009; 36(9):1377-82. DOI: 10.1007/s00259-009-1157-2. View

15.

Gommans G, van Dongen A, van der Schors T, Gommans E, Visser J, Clarijs W . Further optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling. Eur J Nucl Med. 2001; 28(10):1450-5. DOI: 10.1007/s002590100590. View

16.

Vermeeren L, Olmos R, Meinhardt W, Bex A, van der Poel H, Vogel W . Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med. 2009; 50(6):865-70. DOI: 10.2967/jnumed.108.060673. View